Literature DB >> 7903523

Multidrug resistance gene transcript level, and P-glycoprotein expression in paediatric malignant mesenchymal tumours.

H McDowell1, M Peuchmaur, C Dominici, F Flamant.   

Abstract

Twenty-four malignant mesenchymal tumour specimens were analysed for human multidrug resistance (MDRI) gene transcript levels using Northern and slot blot techniques. The presence of P-glycoprotein was assessed in 12 of the 24 samples by immunohistochemistry using the monoclonal antibody (MAb) C219. Increased MDRI transcript levels were found in 2 (8.3%), while, using immunohistochemistry, 2 samples were positive and 3 faintly positive (41.6%). Overall, elevated P-glycoprotein or MDRI transcript levels were found in tumours of 6 patients, 3 of whom are dead. The relationship to MDRI expression and subsequent resistance to chemotherapy has to be established.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7903523

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

Review 1.  Multidrug resistance in pediatric oncology.

Authors:  J F Kuttesch
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

2.  Expression of MDR1/p-glycoprotein and multidrug resistance-associated protein in childhood solid tumours.

Authors:  Y Oda; I Röse; K Radig; W Wagemann; U Mittler; A Roessner
Journal:  Virchows Arch       Date:  1997-02       Impact factor: 4.064

3.  Expression of multidrug-resistance-associated protein gene in human soft-tissue sarcomas.

Authors:  Y Oda; R Schneider-Stock; J Ryś; A Gruchala; A Niezabitowski; A Roessner
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.